Authors



David Hyun, MD

Latest:

Antibiotic Overuse During COVID-19 Pandemic Exacerbates Need for Firmer Prescription Policies, Expert Says

The reality of the COVID-19 pandemic will force lawmakers to firmly act on behalf of antibiotic policies, according to an expert with Pew Charitable Trusts.


Andrew Storer, PhD, DNP, RN, NP, FAANP

Latest:

Your Workforce Should Reflect Your Community

Diversity, equity, and inclusion must be a centerpiece of nursing recruitment and retention.


Johanna Garibaldi, BSN, RN, EMT-P

Latest:

Johanna Garibaldi On Strengthening Cancer Prevention Tactics With Mobile Screening Clinics

Johanna Garibaldi, BSN, RN, EMT-P, discusses how a mobile clinic improved cancer screening rates among local firefighters.


Jessica MacIntyre, DNP, MBA, NP-C, APRN, AOCNP

Latest:

Jessica MacIntyre on Improving LLS Referrals For Patients With Hematologic Malignancies

Jessica MacIntyre, DNP, MBA, APRN, NP-C, AOCNP, discusses ways to standardize the process of referring patients to the Leukemia and Lymphoma Society.


Daniel J. Verina, DNP, RN, MSN, ACNP-BC

Latest:

Verina on Tackling Neurological Toxicities From CAR T-Cell Therapy

Daniel J. Verina, DNP, RN, MSN, ACNP-BC, underscores how nurses can assess neurological toxicities in both the inpatient and outpatient setting.


Jamie Cesanek

Latest:

Forgoing Select Lymph Node Dissection Linked With Superior Outcomes in Early-Stage Breast Cancer

Updates from the ongoing INSEMA trial suggest that patients with early-stage breast cancer maintain superior quality of life by forgoing sentinel lymph node biopsy and axillary lymph node dissection.


Precious Ferguson, MSN, APRN, FNP-BC

Latest:

Supporting the Novice Oncology NP: The Benefits of Preceptorship

Structured preceptorships promote competence, confidence, and job satisfaction in new oncology nurse practitioners.


Lucia Fanjul, LMSW

Latest:

Immediate Interventions to Support The Newly Bereaved

When engaging with a family member of a patient who has died, nurses should consider using immediate interventions aimed at supporting the loved ones who are in shock and in pain following their loss.


Jennifer Cargile, MEd, CCC-SLP

Latest:

Jennifer Cargile on Managing Cancer-Related Cognitive Impairment

Jennifer Cargile, MEd, CCC-SLP, shares some examples of how she helped patients continue their daily activities while they experienced symptoms of cancer-related cognitive impairment.


Chris Ryan

Latest:

Noninvasive Stool RNA Screening Test for CRC Receives FDA Approval

A screening test has been approved by the FDA for adults 45 years of age or older with an average risk for developing colorectal cancer.


Jamie Carroll, APRN, CNP, MSN

Latest:

Practice Pearls for Toxicity Management With ADC Therapy in Breast and Gastric Cancer

Shared practical advice on the management of toxicities associated with antibody drug conjugate therapy in both the breast cancer and GI cancer settings.


Yale Cancer Center

Latest:

Oncology Therapy at the End of Life: Have We Missed the Mark?

"Over the last decade, the landscape of systemic anti-cancer therapy has changed dramatically following the approvals of multiple new targeted therapies," - Kerin Adelson, MD.


Kristine Gibbons, RN, OCN

Latest:

Oncology Drug Crash Course: Elacestrant (Orserdu)

Kristine Gibbons, RN, OCN, who is a Nurse Trainer at Florida Cancer Specialists & Research Institute, provides an in-depth look at elacestrant in a downloadable fact sheet.


Charina Toste, DNP, APRN-C, AOCNP, MSN, BSN, RN

Latest:

Charina Toste Discusses the Educational Obstacles Patients With MPNs Face

According to Charina Toste, DNP, APRN-C, AOCNP, MSN, BSN, RN, patients with newly diagnosed myeloproliferative neoplasms may be unaware of the questions they should be asking their providers.


Erin Burns, PhD

Latest:

Advanced Practice Providers May Hold the Key to Improving Community Clinical Trial Involvement

Seventy-three percent of advanced practice providers reported that they are interested in becoming more involved with clinical trials.


Hussein A. Tawbi, MD, PhD

Latest:

Expert Talks Significance of Relatlimab/Nivolumab Approval for Metastatic Melanoma

Hussein A. Tawbi, MD, PhD, principal investigator of the phase 2/3 RELATIVITY-046 trial, highlights the importance of relatlimab/nivolumab’s recent FDA approval in melanoma.


Marni Jameson Carey

Latest:

Is a Health Care Price Transparency Revolution at Hand?

The Transparency in Coverage Final Rule requires health care payers to unveil all previously secret negotiated prices with in-network providers.



Matt Iwaniec, PsyD

Latest:

Integrated Behavioral Health Vs Standard Practice: What’s The Difference?

A licensed clinical health psychologist with Allegheny Health Network discusses fully integrated behavioral health programs and how their design alleviates potential barriers to care that patients may experience.


Sabrina Serani

Latest:

Apalutamide/ADT Confers 100% Recurrence-Free Survival in High-Risk Prostate Cancer

Patients with high-risk prostate cancer treated with apalutamide with androgen deprivation therapy following radical prostatectomy had a recurrence-free survival rate of 100% after 2 years.


Rina Lokaj

Latest:

Adding Nivolumab to Chemo Increases OS, PFS in Previously Untreated Advanced GI Cancers

Overall survival and progression-free survival improves with nivolumab plus chemotherapy compared with chemotherapy alone in the overall population and in patients with a PD-L1 CPS of 5 or greater.


Ilene Galinsky, BSN, MSN, ANP-C

Latest:

Galinsky Breaks Down Venetoclax Symptom Management in AML

Ilene Galinsky, BSN, MSN, ANP-C, underscores effective symptom management strategies when prescribing venetoclax to patients with acute myeloid leukemia.


Kate Esselen, MD

Latest:

Normalize Conversations Between Patients and Providers on the Financial Costs of Cancer

Nearly half of patients with gynecologic cancer reported financial distress as a result of the high costs of cancer treatment, yet money is still not commonly discussed between patients and providers.


Brenda Martone MSN, ANP-BC, AOCNP

Latest:

Brenda Martone Highlights Nursing Considerations With Darolutamide in Prostate Cancer

Brenda Martone MSN, ANP-BC, AOCNP, discusses what nurses need to know about safely treating patients with darolutamide.


Jeanelle S. King, PA-C

Latest:

Oncology Drug Crash Course: Nivolumab Plus Relatlimab (Opdualag)

Jeanelle S. King, PA-C, provides an in-depth look at nivolumab-relatlimab in a downloadable reference sheet.


Gretchen A. McNally, PhD, ANP-BC, AOCNP

Latest:

Gretchen McNally Speaks to the Role of Oncology Nurses in the Opioid Epidemic

Gretchen McNally PhD, ANP-BC, AOCN, spotlights the value that naloxone training for oncology nurses and providers could have for patients who are at a high-risk of overdose.


Srigowri Kota, MSN, BA, RN, APN, AGNP-C, OCN

Latest:

The Transition from Being an Oncology Nurse in Breast Cancer to an Advanced Practice Nurse in GU Oncology

Overall, the transition from breast to genitourinary cancer has added depth and dimension to my knowledge of cancer care.


Amanda Brink, DNP, APRN, FNP-BC, AOCNP

Latest:

Opinion: CAR T-Cell Therapy as a Promising Avenue in Glioblastoma Treatment

Oncology nurses can educate their patients on the latest developments in CAR T-cell therapy for the treatment of glioblastoma.


Margaret Rabatin, DNP, FNP-BC

Latest:

Complex Cancer Cases: Veno-Occlusive Disease in a Pediatric Patient Receiving Nontransplant-Associated Chemotherapy

Veno-occlusive disease or sinusoidal obstruction syndrome is commonly associated as a complication with transplant in pediatric patients but can also be seen with chemotherapy alone.

© 2024 MJH Life Sciences

All rights reserved.